These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
17. Prophylactic efficacy of phenelzine and imipramine in chronic atypical depression: likelihood of recurrence on discontinuation after 6 months' remission. Stewart JW; Tricamo E; McGrath PJ; Quitkin FM Am J Psychiatry; 1997 Jan; 154(1):31-6. PubMed ID: 8988955 [TBL] [Abstract][Full Text] [Related]
18. Combination monoamine oxidase inhibitor and beta-blocker treatment of migraine, with anxiety and depression. Merikangas KR; Merikangas JR Biol Psychiatry; 1995 Nov; 38(9):603-10. PubMed ID: 8573662 [TBL] [Abstract][Full Text] [Related]
19. An outpatient evaluation of phenelzine and imipramine. Davidson J; Raft D; Pelton S J Clin Psychiatry; 1987 Apr; 48(4):143-6. PubMed ID: 3549705 [TBL] [Abstract][Full Text] [Related]
20. Chronic treatment with the monoamine oxidase inhibitor phenelzine increases hypothalamic-pituitary-adrenocortical activity in male C57BL/6 mice: relevance to atypical depression. Kier A; Han J; Jacobson L Endocrinology; 2005 Mar; 146(3):1338-47. PubMed ID: 15564336 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]